SHPHF / Sihuan Pharmaceutical Holdings Group Ltd. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Sihuan Pharmaceutical Holdings Group Ltd.
US ˙ OTCPK ˙ BMG8162K1137

Mga Batayang Estadistika
LEI 529900UD7C9N3AQO1V88
CIK 1556609
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Sihuan Pharmaceutical Holdings Group Ltd.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
November 22, 2019 EX-99.(D)

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 15, 2019

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 15, 2019 JPMorgan Chase Bank, N.

November 22, 2019 EX-99.(E)

Certification under Rule 466

EX-99.(E) 4 e618833ex99-e.htm Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6Pos (Knorr-Bremse AG 333-227925) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to desi

November 22, 2019 F-6EF

DMLRY / Daimler AG F-6EF - -

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or organization of Issuer) JPMorgan Chase Bank, N

November 22, 2019 EX-99.(A)

JPMorgan Chase Bank, N.A. American Depositary Receipt American Depositary Shares Representing Ordinary Shares of Sihuan Pharmaceutical Holdings Group Ltd (Incorporated under the laws of Bermuda)

Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N.

August 26, 2016 EX-99.(E)

Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Berkeley Group Holdings Plc, 333-198831) that the Commission declar

Unassociated Document Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.

August 26, 2016 F-6 POS

Sihuan Pharmaceutical Holdings POS

333-209261 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or o

August 26, 2016 EX-99.(A)

Number Each American Depositary Share represents Forty Shares

Unassociated Document Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N.

August 26, 2016 EX-99.(A)

Number Each American Depositary Share represents Forty Shares

Unassociated Document Number Each American Depositary Share represents Forty Shares JPMorgan Chase Bank, N.

August 26, 2016 F-6 POS

Sihuan Pharmaceutical Holdings POS

333-209261 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or o

August 26, 2016 EX-99.(E)

Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Berkeley Group Holdings Plc, 333-198831) that the Commission declar

Unassociated Document Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.

March 27, 2013 EX-99.(D)

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 March 27, 2013 Deutsche Bank Trust Company Americas, as Depositary 60 Wall Street New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited shares of the foreign private issuer whose name appears on

March 27, 2013 EX-99.(E)

Certification under Rule 466

Certification under Rule 466 The depositary, Deutsche Bank Trust Company Americas, represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Finmeccanica SpA 333-170944) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement.

March 27, 2013 F-6EF

-

F-6EF 1 e610764f6ef-sph.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Sihuan Pharmaceutical Holdings Group Ltd. (Exact name of Issuer of deposited securities as specified in its charter) Bermuda (Jurisdiction of Incorporation or organization of I

March 27, 2013 EX-99.(A)

Each American Depositary Share represents Forty Shares Deutsche Bank Trust Company Americas American Depositary Receipt Evidencing American Depositary Shares For Ordinary Shares of Sihuan Pharmaceutical Holdings Group Ltd. (Incorporated under the law

Number Each American Depositary Share represents Forty Shares Deutsche Bank Trust Company Americas American Depositary Receipt Evidencing American Depositary Shares For Ordinary Shares of Sihuan Pharmaceutical Holdings Group Ltd.

August 29, 2012 F-6EF

- FORM F-6

As filed with the Securities and Exchange Commission on August 29, 2012 Registration No.

August 29, 2012 EX-4

EMMET, MARVIN & MARTIN, LLP

Writer’s Direct Dial EXHIBIT 4 EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.

August 29, 2012 EX-1

THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (INCORPORATED UNDER THE LAWS OF BERMUDA)

EX-1 2 sihuanreceipt.htm FORM OF RECEIPT AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents Forty (40) Shares) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR ORDINARY SHARES OF SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD. (INCORPORATED UNDER THE LAWS OF BERMUDA) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) th

Other Listings
DE:TEL1
HK:460 HK$ 1.65
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista